We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Image: A new study validated a genetic scoring tool designed to help physicians diagnose idiopathic pulmonary fibrosis and stratify risk for severe outcomes, including death or lung transplantation (Image Credit: Adobe Stock)

Genetic Risk Score Supports Diagnosis and Prognosis in Idiopathic Pulmonary Fibrosis

New data validate a polygenic risk score that aids IPF diagnosis and predicts death or lung transplant risk. More...
09 Jul 2026
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

New findings link genetic and biological markers to treatment resistance in BPDCN, helping guide patient stratification. More...
09 Jul 2026
Image: Graphical Abstract (Choi, B. H., H. An, S. Cho, et al. Journal of Extracellular Vesicles, 2026. https://doi.org/10.1002/jev2.70264)

Extracellular Vesicle Marker Identifies Early Lung Adenocarcinoma and Predicts Recurrence

A new blood-based test measuring a vesicle-related biomarker detects early lung adenocarcinoma and predicts recurrence. More...
09 Jul 2026
Image: Performed on Roche’s cobas immunoassay systems, the test helps laboratories meet growing tuberculosis testing needs by automating workflows (Photo courtesy of Roche)

CE-Marked Blood Assay Automates Tuberculosis Infection Testing

Roche receives CE mark for a blood assay designed to identify tuberculosis infection in routine clinical laboratories. More...
09 Jul 2026
Image: Overview of the self-supervised learning method DINOv2 applied to digital pathology. (Witowski, J., Zeng, K.G., Cappadona, J. et al. Nature Communication, 2026. https://doi.org/10.1038/s41467-026-73088-y)

New AI Test Delivers Rapid Breast Cancer Recurrence Predictions

An AI test estimates breast cancer recurrence risk from routine slides and data, matching genomic assays and enabling faster care. More...
09 Jul 2026
Image Credit: Adobe Stock

Training Device Improves Accuracy of Pooled Molecular Diagnostics

A new device trains and assists novices to accurately perform pooled NAATs, reducing errors and expanding access. More...
09 Jul 2026
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

New findings link genetic and biological markers to treatment resistance in BPDCN, helping guide patient stratification. More...
09 Jul 2026
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Copyright © 2000-2026 Globetech Media. All rights reserved.